PANDAS/PANS Package will be reported without Dopamine receptor 2 due to reagent shortage

June 27, 2014 - Company News, Product News, Disease Area News
We are experiencing a temporary manufacturing shortage of Dopamine receptor 2 which impacts 1 of the 5 assays in the PANDAS /PANS test panel.

We will be performing assays and providing results for the remaining 4 assays until the reagent shortage is resolved. In the majority of patients there is a high cross-reactivity and the patients are positive in more than one of the tests (Beta Tubulin, Dopamine receptor 1, Dopamine receptor 2 and Lyso-GM1). Dopamine receptor 2 has in rare occasions been positive without parallel reaction in other tests. Thank you for your patience as we work to keep up with the testing requests and secure a continuous supply of these reagents.

If you have any questions you are welcome to contact us.

Michael Akoh
Wieslab Director
Tel: +46 40 53 76 31

« Back
Clinical studies